Returns | 1W : 24% , 1M : 31.4%,1Y : 4.2% |
LT :   |
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Average |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : High [>50%] |
Peers & Returns | 1W | 1M | 1Y |
DR AGARWALS EYE HOSPITAL LTD | 24% | 31.4% | 4.2% |
APOLLO HOSPITALS ENTERPRISE LTD | -0.3% | 6.9% | 58.1% |
DR LAL PATHLABS LTD | 2.9% | 3.2% | 44% |
FORTIS HEALTHCARE LTD | 1.2% | 7.5% | 8.1% |
METROPOLIS HEALTHCARE LTD | -0% | 12.1% | 35.6% |
ASTER DM HEALTHCARE LTD | 0.4% | -5.5% | -1.7% |
NARAYANA HRUDAYALAYA LTD | 1.9% | 7.6% | 32% |
THYROCARE TECHNOLOGIES LTD | -2.9% | -0.9% | 67.5% |
SHALBY LTD | -2.9% | 3.6% | 11.3% |
Ratio | Value |
---|---|
P/E P/B P/S |
11.51
P/E Calculated based on EPS of 29.11
[ Mar2020 - Standalone Results ] 2.81
P/B Calculated based on Book Value of 119.36
[ Mar2020 - Standalone Results ] 1.09
P/S Calculated based on Revenues of 144.446 Cr
[ TTM - Standalone Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 82% 133% |
Pledged Shares |
98.82 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |